KRAKOW, Poland, March 27, 2025 /PRNewswire/ -- Selvita S.A. (WSE: SLV), one of Europe's leading preclinical CROs, has announced its financial results for 2024 and provided an update on its backlog for 2025. Key Highlights: In Q4 2024, Selvita generated EUR 22.5 million in commercial...
Hence then, the article about selvita reports rebound in h2 2024 and 11 increase in backlog for 2025 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Selvita Reports Rebound in H2 2024 and 11% Increase in Backlog for 2025 )
Also on site :
- Most Australian teens admit the social media ban isn’t working as they try to sidestep age verification blocks with face masks and their parents’ IDs
- The New ‘Silent Travel’ Trend: Why Some Travelers Are Choosing Destinations With No Wi-Fi
- This Is the 'Fairy Godmother' Heat Protectant Spray That Hairstylists Swear By